CLINICAL OUTCOME OF AN PROSPECTIVE, MULTICENTRE, RANDOMIZED, PHASE III NON-INFERIORITY CLINICAL TRIAL FOR PATIENTS WITH EXTRANODAL NK/T CELL LYMPHOMA TREATED BY P-GEMOX OR AspaMetDex

Authors :: H. Huang
Y. Gao
H. Su
Y. Huang
X. Wang
B. Bai
Y. Zhang
L. Su
X. Chu
W. Li
J. Zhang
Q. Zhang
L. Zhang
X. Hu
L. Zou
Z. Li
W. Jiang
Source :: Hematological Oncology. 37:161-163
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Hematology
General Medicine
GemOx
medicine.disease
Clinical trial
Non inferiority
Internal medicine
medicine
T-cell lymphoma
business

Full Text Access

Tools